{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:28:02Z","timestamp":1793744882375,"version":"4.6.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gore.2026.102200","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:45:15Z","timestamp":1787931915000},"page":"102200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A comprehensive model for gynecologic cancer patients' survivorship care"],"prefix":"10.1016","volume":"67","author":[{"given":"Victoria E.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Frankenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Walchonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2026.102200_bb0005","doi-asserted-by":"crossref","unstructured":"Archer DF, Goldstein SR, Simon JA, Waldbaum AS, Sussman SA, Altomare C, et al. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial. Menopause 2019;26(6):611\u201321. doi:10.1097\/GME.0000000000001292 PubMed PMID: 30694917; PubMed Central PMCID: PMC6553508.","DOI":"10.1097\/GME.0000000000001292"},{"issue":"6","key":"10.1016\/j.gore.2026.102200_bb0010","doi-asserted-by":"crossref","first-page":"817.e1","DOI":"10.1016\/j.ajog.2021.12.012","article-title":"Risk factors for financial toxicity in patients with gynecologic cancer","volume":"226","author":"Aviki","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gore.2026.102200_bb0015","doi-asserted-by":"crossref","unstructured":"Azam F, Latif MF, Farooq A, Tirmazy SH, AlShahrani S, Bashir S, et al. Performance status assessment by using ECOG (Eastern Cooperative Oncology Group) score for Cancer patients by oncology healthcare professionals. Case Rep. Oncol. 2019;12(3):728\u201336. doi:10.1159\/000503095 PubMed PMID: 31616281; PubMed Central PMCID: PMC6792426.","DOI":"10.1159\/000503095"},{"key":"10.1016\/j.gore.2026.102200_bb0020","doi-asserted-by":"crossref","unstructured":"Barakat RR, Bundy BN, Spirtos NM, Bell J, Mannel RS, Gynecologic Oncology Group Study. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group study. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2006;24(4):587\u201392. doi:https:\/\/doi.org\/10.1200\/JCO.2005.02.8464 (PubMed PMID: 16446331).","DOI":"10.1200\/JCO.2005.02.8464"},{"issue":"6","key":"10.1016\/j.gore.2026.102200_bb0025","first-page":"805","article-title":"Persistence of endometrial activity after radiation therapy for cervical carcinoma","volume":"66","author":"Barnhill","year":"1985","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2020.07.029","article-title":"When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer","volume":"159","author":"Beesley","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13045","article-title":"Relating neurosteroid modulation of inhibitory neurotransmission to behaviour","volume":"34","author":"Belelli","year":"2022","journal-title":"J. Neuroendocrinol."},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pon.5763","article-title":"Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors","volume":"31","author":"Benedict","year":"2022","journal-title":"Psychooncology"},{"key":"10.1016\/j.gore.2026.102200_bb0045","doi-asserted-by":"crossref","unstructured":"Bhinder JK, Kennedy SKF, Faouk Al Aadah C, Al-Khaifi M. 2024 SOGC, 2024 NCCN, 2022 ESO-ESMO, and 2018 ASCO: a comparison of female cancer survivorship guidelines for the management of sexual health concerns. Support Care Cancer 2025;33(7):584. doi:https:\/\/doi.org\/10.1007\/s00520-025-09640-1 PubMed PMID: 40518469.","DOI":"10.1007\/s00520-025-09640-1"},{"key":"10.1016\/j.gore.2026.102200_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.maturitas.2018.02.010","article-title":"Decision-making for the treatment of climacteric symptoms using the menopause rating scale","volume":"111","author":"Bl\u00fcmel","year":"2018","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.gore.2026.102200_bb0055","first-page":"263","article-title":"Nutrition and physical activity guideline for cancer survivors","volume":"72","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.soncn.2019.02.006","article-title":"Caring for survivors of gynecologic Cancer: assessment and Management of Long-term and Late Effects","volume":"35","author":"Campbell","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/pon.1875","article-title":"The psychosocial impact of interrupted childbearing in long-term female cancer survivors","volume":"21","author":"Canada","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.gore.2026.102200_bb0070","doi-asserted-by":"crossref","unstructured":"Cartmel B, Hughes M, Ercolano EA, Gottlieb L, Li F, Zhou Y, et al. Randomized trial of exercise on depressive symptomatology and brain derived neurotrophic factor (BDNF) in ovarian cancer survivors: the women's activity and lifestyle study in Connecticut (WALC). Gynecol. Oncol. 2021a;161(2):587\u201394. doi:10.1016\/j.ygyno.2021.02.036 PubMed PMID: 33773809; PubMed Central PMCID: PMC8085084.","DOI":"10.1016\/j.ygyno.2021.02.036"},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ygyno.2021.02.036","article-title":"Randomized trial of exercise on depressive symptomatology and brain derived neurotrophic factor (BDNF) in ovarian cancer survivors: the women\u2019s activity and lifestyle study in Connecticut (WALC)","volume":"161","author":"Cartmel","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.gore.2026.102200_bb0080","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/ijgc-2019-001034","article-title":"Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma","volume":"30","author":"Chambers","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2026.102200_bb0085","doi-asserted-by":"crossref","unstructured":"Cho L, Kaunitz AM, Faubion SS, Hayes SN, Lau ES, Pristera N, et al. Rethinking menopausal hormone therapy: for whom, what, when, and how long? Circulation 2023;147(7):597\u2013610. doi:10.1161\/CIRCULATIONAHA.122.061559 PubMed PMID: 36780393; PubMed Central PMCID: PMC10708894.","DOI":"10.1161\/CIRCULATIONAHA.122.061559"},{"issue":"3","key":"10.1016\/j.gore.2026.102200_bb0090","first-page":"2317","article-title":"Mindfulness-based cognitive therapy for fear of recurrence in ovarian Cancer survivors (FROCS): a single-arm, open-label, pilot study","volume":"30","author":"Cohen","year":"2022","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.gore.2026.102200_bb0095","doi-asserted-by":"crossref","unstructured":"Custers JAE, Kwakkenbos L, Wal M van de Prins JB, Thewes B. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale [Internet]. doi:https:\/\/doi.org\/10.1002\/pon.4782.","DOI":"10.1002\/pon.4782"},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2017.06.013","article-title":"Management of menopausal symptoms in women with gynecologic cancers","volume":"146","author":"del Carmen","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102200_bb0105","doi-asserted-by":"crossref","unstructured":"Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, et al. Survivorship, version 2.2017. J. Natl. Compr. Cancer Netw. JNCCN 2017;15(9):1140\u201363. doi:https:\/\/doi.org\/10.6004\/jnccn.2017.0146 PubMed PMID: 28874599; PubMed Central PMCID: PMC5865602.","DOI":"10.6004\/jnccn.2017.0146"},{"issue":"3","key":"10.1016\/j.gore.2026.102200_bb0110","first-page":"228","article-title":"Validation of the MENQOL for use with women who have been treated for gynecologic or breast cancer","volume":"28","author":"Dolye","year":"2018","journal-title":"Can. Oncol. Nurs. J."},{"issue":"35","key":"10.1016\/j.gore.2026.102200_bb0115","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.2015.60.9719","article-title":"Adjuvant hormone therapy may improve survival in epithelial ovarian Cancer: results of the AHT randomized trial","volume":"33","author":"Eeles","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.gore.2026.102200_bb0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the North American Menopause Society","volume":"29","author":"Faubion","year":"2022","journal-title":"Menopause"},{"issue":"12","key":"10.1016\/j.gore.2026.102200_bb0125","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s11920-013-0418-8","article-title":"Insomnia and its impact on physical and mental health","volume":"15","author":"Fernandez-Mendoza","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.gore.2026.102200_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.818718","article-title":"Optimizing a behavioral sleep intervention for gynecologic cancer survivors: study design and protocol","volume":"16","author":"Fox","year":"2022","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.gore.2026.102200_bb0135","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/ijgc-2024-005300","article-title":"Evidence and best practices for trauma-informed care in gynecologic oncology patients","volume":"34","author":"Fulton","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7","key":"10.1016\/j.gore.2026.102200_bb0140","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.pec.2021.11.020","article-title":"The needs of gynecological cancer survivors at the end of primary treatment: a scoping review and proposed model to guide clinical discussions","volume":"105","author":"Galica","year":"2022","journal-title":"Patient Educ. Couns."},{"issue":"10","key":"10.1016\/j.gore.2026.102200_bb0145","first-page":"629","article-title":"Gynecologic cancer survivor preferences for provider communication regarding sexual health after treatment: a qualitative study","volume":"32","author":"Girard","year":"2024","journal-title":"Support. Care Cancer"},{"issue":"6","key":"10.1016\/j.gore.2026.102200_bb0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/GME.0000000000002723","article-title":"Tailoring transdermal estradiol dose to maximize benefits and minimize risks","volume":"33","author":"Glynne","year":"2026","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0155","first-page":"447","article-title":"Improvements in strength and agility measures of functional fitness following a telehealth-delivered home-based exercise intervention in endometrial cancer survivors","volume":"30","author":"Gorzelitz","year":"2022","journal-title":"Support. Care Cancer"},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11764-021-00990-3","article-title":"Feasibility and acceptability of home-based strength training in endometrial cancer survivors","volume":"17","author":"Gorzelitz","year":"2023","journal-title":"J. Cancer Surviv."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ygyno.2006.08.036","article-title":"Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes","volume":"104","author":"Hodgkinson","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102200_bb0170","doi-asserted-by":"crossref","unstructured":"Hodis HN, Mack WJ. Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: it is about time and timing. Cancer J. (Sudbury Mass.) 2022;28(3):208\u201323. doi:10.1097\/PPO.0000000000000591 PubMed PMID: 35594469; PubMed Central PMCID: PMC9178928.","DOI":"10.1097\/PPO.0000000000000591"},{"key":"10.1016\/j.gore.2026.102200_bb0175","doi-asserted-by":"crossref","unstructured":"Huffman LB, Hartenbach EM, Carter J, Rash JK, Kushner DM. Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide. Gynecol. Oncol. 2016;140(2):359\u201368. doi:10.1016\/j.ygyno.2015.11.010 PubMed PMID: 26556768; PubMed Central PMCID: PMC4835814.","DOI":"10.1016\/j.ygyno.2015.11.010"},{"key":"10.1016\/j.gore.2026.102200_bb0180","doi-asserted-by":"crossref","unstructured":"Jensen RE, Potosky AL, Reeve BB, Hahn E, Cella D, Fries J, et al. Validation of the PROMIS physical function measures in a diverse U.S. population-based cohort of cancer patients. Qual. Life Res. 2015;24(10):2333\u201344. doi:https:\/\/doi.org\/10.1007\/s11136-015-0992-9 PubMed PMID: 25935353; PubMed Central PMCID: PMC5079641.","DOI":"10.1007\/s11136-015-0992-9"},{"issue":"3","key":"10.1016\/j.gore.2026.102200_bb0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/JU.0000000000004589","article-title":"The AUA\/SUFU\/AUGS guideline on genitourinary syndrome of menopause","volume":"214","author":"Kaufman","year":"2025","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.gore.2026.102200_bb0190","article-title":"How healthy are the diets of Cancer survivors? Characteristics of those most at risk and opportunities for improvement","volume":"23","author":"Kaur","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41416-024-02694-8","article-title":"Effects of a combined exercise and dietary intervention on body composition, physical functioning and fatigue in patients with ovarian cancer: results of the PADOVA trial","volume":"131","author":"Kenkhuis","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.gore.2026.102200_bb0200","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/pon.4731","article-title":"Fear of recurrence among older breast, ovarian, endometrial, and colorectal cancer survivors: findings from the WHI LILAC study","volume":"27","author":"Krok-Schoen","year":"2018","journal-title":"Psychooncology"},{"key":"10.1016\/j.gore.2026.102200_bb0205","article-title":"Evaluation of the stronger together peer mentoring model among patients with breast and gynecologic Cancer in Viet Nam","volume":"10","author":"Le","year":"2024","journal-title":"JCO Glob Oncol."},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000005553","article-title":"A contemporary view of menopausal hormone therapy","volume":"144","author":"Levy","year":"2024","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ygyno.2007.10.009","article-title":"A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach","volume":"108","author":"Liavaag","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/07399330500377507","article-title":"Factors related to depressive symptoms among long-term survivors of cervical Cancer","volume":"27","author":"Mccorkle","year":"2006","journal-title":"Health Care Women Int."},{"key":"10.1016\/j.gore.2026.102200_bb0225","doi-asserted-by":"crossref","unstructured":"McDowell JL, Strawderman M, Betstadt SJ, Moore RG. Estrogen therapy in patients with gynecologic cancer: a survey of gynecologists and oncologists in the United States. Menopause 2024;https:\/\/doi.org\/10.1097\/GME.0000000000002643. doi:https:\/\/doi.org\/10.1097\/GME.0000000000002643.","DOI":"10.1097\/GME.0000000000002643"},{"issue":"12","key":"10.1016\/j.gore.2026.102200_bb0230","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/pon.6055","article-title":"Psychosocial predictors of fear of cancer recurrence in a cohort of gynecologic cancer survivors","volume":"31","author":"Mell","year":"2022","journal-title":"Psychooncology"},{"issue":"3","key":"10.1016\/j.gore.2026.102200_bb0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ygyno.2020.12.019","article-title":"Comparisons of emotional health by diagnosis among women with early stage gynecological cancers","volume":"160","author":"Messelt","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102200_bb0240","doi-asserted-by":"crossref","unstructured":"Mishra N, Singh N, Sachdeva M, Ghatage P. Sexual dysfunction in cervical cancer survivors: a scoping review. Women's Health Rep. 2021; 2(1):594\u2013607. doi:10.1089\/whr.2021.0035 PubMed PMID: 35141708; PubMed Central PMCID: PMC8820405.","DOI":"10.1089\/whr.2021.0035"},{"key":"10.1016\/j.gore.2026.102200_bb0245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2023.06.015","article-title":"Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer","volume":"175","author":"Morton","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.gore.2026.102200_bb0250","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.gore.2026.102200_bb0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2023.02.015","article-title":"Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors","volume":"171","author":"Osann","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0260","first-page":"175","article-title":"Use of the distress thermometer in clinical practice","volume":"10","author":"Ownby","year":"2019","journal-title":"J. Adv. Pract. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0265","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jval.2022.07.017","article-title":"Comprehensive score for financial toxicity and health-related quality of life in patients with Cancer and survivors: a systematic review and Meta-analysis","volume":"26","author":"Pangestu","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.gore.2026.102200_bb0270","doi-asserted-by":"crossref","unstructured":"Pennacchini E, Dall'Alba R, Iapaolo S, Marinelli M, Palazzetti PL, Zullo MA, et al. Treatment of genitourinary syndrome of menopause in breast cancer and gynecologic cancer survivors: retrospective analysis of efficacy and safety of vaginal estriol, vaginal dehydroepiandrosterone and ospemifene. J. Menopausal Med. 2024;30(3):170\u20138. doi:10.6118\/jmm.24011 (PubMed PMID: 39829194; PubMed Central PMCID: PMC11745731).","DOI":"10.6118\/jmm.24011"},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0275","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1148\/99.2.417","article-title":"Postirradiation vaginitis. An evaluation of prophylaxis with topical estrogen","volume":"99","author":"Pitkin","year":"1971","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0280","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/13548506.2022.2110270","article-title":"Prevalence of sexual dysfunction in women with cervical cancer: a systematic review and meta-analysis","volume":"28","author":"Qian","year":"2023","journal-title":"Psychol. Health Med."},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1891\/CJNPWH-2510","article-title":"Understanding and prescribing menopausal hormone therapy for vasomotor symptoms","volume":"2","author":"Quaile","year":"2025","journal-title":"Clin J Nurse Pract Womens Health."},{"issue":"1","key":"10.1016\/j.gore.2026.102200_bb0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2021.01.033","article-title":"Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors","volume":"161","author":"Rahimy","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2026.102200_bb0295","first-page":"230","article-title":"American Cancer Society nutrition and physical activity guideline for cancer survivors","volume":"72","author":"Rock","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.gore.2026.102200_bb0300","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s11136-023-03386-1","article-title":"Sexual quality of life in young gynaecological cancer survivors: a qualitative study","volume":"32","author":"Roussin","year":"2023","journal-title":"Qual. Life Res."},{"issue":"4","key":"10.1016\/j.gore.2026.102200_bb0305","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ijgc-2020-002145","article-title":"Long-term quality of life outcomes of women treated for early-stage endometrial cancer","volume":"31","author":"Sanjida","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"6","key":"10.1016\/j.gore.2026.102200_bb0310","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41416-022-01901-8","article-title":"Pre-diagnosis and post-diagnosis dietary patterns and survival in women with ovarian cancer","volume":"127","author":"Sasamoto","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gore.2026.102200_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2020.103768","article-title":"Effects of a nurse-led positive psychology intervention on sexual function, depression and subjective well-being in postoperative patients with early-stage cervical cancer: a randomized controlled trial","volume":"111","author":"Shi","year":"2020","journal-title":"Int. J. Nurs. Stud."},{"issue":"9","key":"10.1016\/j.gore.2026.102200_bb0320","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","article-title":"Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis","volume":"50","author":"Shim","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.gore.2026.102200_bb0325","doi-asserted-by":"crossref","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA 2025;75(1):10\u201345. doi:10.3322\/caac.21871 PubMed PMID: 39817679; PubMed Central PMCID: PMC11745215.","DOI":"10.3322\/caac.21871"},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0330","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2020.01.035","volume":"157","author":"Sinno","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.gore.2026.102200_bb0335","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1177\/1359105317740737","article-title":"Impact of coping strategies on perceived stress, depression, and cortisol profiles among gynecologic cancer patients","volume":"25","author":"Siwik","year":"2020","journal-title":"J. Health Psychol."},{"issue":"15","key":"10.1016\/j.gore.2026.102200_bb0340","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMra2202438","article-title":"Sex hormone influences on venous thrombotic and cardiovascular risk","volume":"394","author":"Skeith","year":"2026","journal-title":"N. Engl. J. Med."},{"issue":"165","key":"10.1016\/j.gore.2026.102200_bb0345","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.maturitas.2022.07.010","article-title":"Sexual dysfunction in female cancer survivors: addressing the problems and the remedies","volume":"1","author":"Smith","year":"2022","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.gore.2026.102200_bb0350","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/ijgc-2023-005054","article-title":"Financial toxicity in gynecologic oncology: a multi-practice survey","volume":"34","author":"Smith","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.gore.2026.102200_bb0355","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/AOG.0000000000006226","article-title":"Elimination of the black box warning on menopausal hormone therapy","volume":"147","author":"Sriprasert","year":"2026","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.gore.2026.102200_bb0360","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/20533691241286666","article-title":"British Gynaecological Cancer society and British menopause society guidelines: management of menopausal symptoms following treatment of gynaecological cancer","volume":"30","author":"Taylor","year":"2024","journal-title":"Post Reprod Health."},{"key":"10.1016\/j.gore.2026.102200_bb0365","series-title":"Menopause Practice: A Clinician\u2019s Guide","author":"The North American Menopause Society (NAMS)","year":"2023"},{"key":"10.1016\/j.gore.2026.102200_bb0370","doi-asserted-by":"crossref","unstructured":"Thomson CA, Crane TE, Miller A, Gold MA, Powell M, Bixel K, et al. Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG\/GOG0225): recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors. Gynecol. Oncol. 2023;170:11\u20138. doi:10.1016\/j.ygyno.2022.12.017 PubMed PMID: 36608382; PubMed Central PMCID: PMC10023359.","DOI":"10.1016\/j.ygyno.2022.12.017"},{"issue":"8","key":"10.1016\/j.gore.2026.102200_bb0375","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jpen.2688","article-title":"Malnutrition risk screening in adult oncology outpatients: an ASPEN systematic review and clinical recommendations","volume":"48","author":"Trujillo","year":"2024","journal-title":"JPEN. J. Parenter. Enteral Nutr."},{"issue":"5","key":"10.1016\/j.gore.2026.102200_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051443","article-title":"Hormone replacement therapy in post-menopause hormone-dependent gynecological cancer patients: a narrative review","volume":"13","author":"Villa","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.gore.2026.102200_bb0385","doi-asserted-by":"crossref","unstructured":"von Kartaschew \u00c5E, Dahm-K\u00e4hler P, Rodriguez Wallberg K, Holmberg E, Fl\u00f6ter-R\u00e5destad A. Menopausal hormone therapy after ovarian cancer: a 10-year survival analysis in premenopausal women. Acta Obstet. Gynecol. Scand. 2026;105(8):1468\u201379. doi:10.1111\/aogs.70242 PubMed PMID: 42161357; PubMed Central PMCID: PMC13356480.","DOI":"10.1111\/aogs.70242"},{"issue":"4","key":"10.1016\/j.gore.2026.102200_bb0390","first-page":"308","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0395","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11764-015-0472-9","article-title":"Survivors of gynecologic malignancies: impact of treatment on health and well-being","volume":"10","author":"Westin","year":"2016","journal-title":"J. Cancer Surviv."},{"issue":"2","key":"10.1016\/j.gore.2026.102200_bb0400","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/aogs.14710","article-title":"Anxiety and depression among women with newly diagnosed vulvar cancer \u2013 a nationwide longitudinal study","volume":"103","author":"Zach","year":"2024","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.gore.2026.102200_bb0405","doi-asserted-by":"crossref","unstructured":"Zhou Y, Cartmel B, Gottlieb L, Ercolano EA, Li F, Harrigan M, et al. Randomized trial of exercise on quality of life in women with ovarian cancer: women's activity and lifestyle study in Connecticut (WALC). J. Natl. Cancer Inst. 2017; 109(12):djx072. doi:https:\/\/doi.org\/10.1093\/jnci\/djx072 (PubMed PMID: 30053074; PubMed Central PMCID: PMC6515522).","DOI":"10.1093\/jnci\/djx072"}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:02:01Z","timestamp":1793743321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926001803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":81,"alternative-id":["S2352578926001803"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102200","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive model for gynecologic cancer patients' survivorship care","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102200"}}